Ochsner Health physicians Dr. Richard Zweifler and Dr. Joseph Tarsia are co-authors on a post hoc analysis carried out in the ...

Lawyers for AstraZeneca, Bristol-Myers Squibb, and Johnson & Johnson argued at a panel hearing in Philadelphia late last week ...

Pfizer chief executive Albert Bourla hit back at Starboard Value in its third-quarter results call, criticising the activist ...

Apixaban is a generic oral tablet that’s prescribed for certain types of blood clots. It’s available as the brand-name drug Eliquis. The cost of apixaban, with and without insurance ...

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

More than 1,000 people took part in the UK-wide trial of the blood thinner Apixaban while in hospital with Covid. The Addenbrooke's Hospital and University of Cambridge study aims to find a ...

Amid a share value slump and executive turmoil, Pfizer reported a robust quarter, thanks in part to Covid-19 drug sales.

comparing the effectiveness of apixaban versus aspirin in preventing ... They strike in the middle of the night without warning. A painful contraction of the calf muscle wrenches sleepers out of ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Fresh or canned sardines are a healthy part of most people's diet due to the omega-3s, calcium, and essential nutrients.

The findings of this post hoc analysis suggest that both apixaban and aspirin may be effective in preventing adverse clinical outcomes in patients with a history of cancer and cryptogenic stroke.